Admission Date:  [**2181-9-8**]              Discharge Date:   [**2181-9-26**]  Date of Birth:  [**2119-11-6**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins  Attending:[**First Name3 (LF) 330**] Chief Complaint: productive cough, shortness of breath  Major Surgical or Invasive Procedure: Placement of PICC line   History of Present Illness: 61 y/o male with history of right lung Non Small Cell Cancer, s/p right upper lobe lobectomy, severe COPD, and a history of MRSA and psuedomanous PNA who presents from ED to ICU with hypoxia and possible PNA.
He recently had a 3 week hospitalization for COPD exacerbation and treated for a pneumonia with Bactrim (for MRSA) and levaquin (for pseudomonas).
Pt was treated with vancomycin and ceftaz during this hospital course, and was discharged on prednisone taper.
His pulmonologist (Dr. [**Last Name (STitle) 14069**] was contact[**Name (NI) **] and recommended transfer to [**Hospital1 18**] for possible bronchoscopy to figure out why he is having recurrent COPD flares.
Non-small cell lung cancer, s/p R upper lobectomy, partial R fifth rib resection c/b chronic pain.
COPD w/ severely reduced DLCO, FEV1, and FEV1/FVC ratio 3. h/o MRSA and pseudomonas PNA 4  UC - s/p multiple surgeries, most recently in late 80s.
S/P total colectomy and ileostomy 5.
Has 3 sisters, all older than him, healthy   Physical Exam: Vitals - T 95.9, HR 95, BP 107/58, RR 20, O2 97% on high flow face mask General - awake alert, sitting up in bed, mask on, NAD HEENT - PERRL, EOMI, dry MM CVS - slightly tachycardic, no noted m/r/g Lungs - diffuse insp and exp wheezes, scattered coarse rhonci at bases, bronchial breath sounds on right middle airfield Abd - tense, non-tender, ileostomy in place Ext - no LE edema b/l   Pertinent Results: ADMISSION LABS: [**2181-9-8**] 10:15PM BLOOD WBC-9.3 RBC-3.40* Hgb-10.0* Hct-28.8* MCV-85 MCH-29.4 MCHC-34.6 RDW-15.4 Plt Ct-280# [**2181-9-8**] 10:15PM BLOOD Neuts-80* Bands-10* Lymphs-3* Monos-6 Eos-0 Baso-0 Atyps-0 Metas-1* Myelos-0 NRBC-1* [**2181-9-8**] 10:15PM BLOOD PT-16.1* PTT-31.4 INR(PT)-1.5* [**2181-9-8**] 10:15PM BLOOD Glucose-262* UreaN-65* Creat-2.8*# Na-129* K-4.1 Cl-87* HCO3-24 AnGap-22* [**2181-9-9**] 05:39AM BLOOD ALT-122* AST-155* LD(LDH)-347* AlkPhos-118* Amylase-64 TotBili-0.5 [**2181-9-10**] 05:10AM BLOOD ALT-79* AST-52* LD(LDH)-311* AlkPhos-115 TotBili-0.4 [**2181-9-13**] 04:14AM BLOOD ALT-14 AST-1 LD(LDH)-255* AlkPhos-108 TotBili-0.3 [**2181-9-9**] 05:39AM BLOOD Lipase-12 [**2181-9-10**] 05:10AM BLOOD Lipase-13 [**2181-9-9**] 05:39AM BLOOD Albumin-2.5* Calcium-7.7* Phos-6.6*# Mg-2.1 [**2181-9-13**] 04:14AM BLOOD calTIBC-160* Ferritn-1317* TRF-123* [**2181-9-9**] 08:26AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE IgM HBc-NEGATIVE IgM HAV-NEGATIVE [**2181-9-9**] 08:26AM BLOOD HCV Ab-NEGATIVE [**2181-9-9**] 01:59AM BLOOD Type-ART pO2-110* pCO2-40 pH-7.38 calTCO2-25 Base XS-0 Intubat-NOT INTUBA [**2181-9-8**] 10:31PM BLOOD Lactate-2.4* Pertinent Labs/Studies: .
New right middle lung opacification most consistent with newly developing pneumonia given acuity of onset (1 month).
[**2181-9-26**] 05:25AM BLOOD WBC-8.2 RBC-3.03* Hgb-9.5* Hct-25.7* MCV-85 MCH-31.4 MCHC-37.1* RDW-16.6* Plt Ct-179 [**2181-9-26**] 05:25AM BLOOD Glucose-118* UreaN-22* Creat-0.7 Na-134 K-3.6 Cl-95* HCO3-30 AnGap-13 [**2181-9-26**] 05:25AM BLOOD Calcium-8.3* Phos-3.2 Mg-1.6  Brief Hospital Course: 61 y/o M w/ h/o NSCLC s/p RUL lobectomy, severe COPD, recurrent pna over past couple months, with righ sided PNA (MRSA/Pseudomonas) and severe hypoxia requiring significant O2 suppplementation.
Patient was initially treated with high flow face mask of 15 L at 40% with additional NC with saturations varying from 88 to 98%, but with continued frequent coughing which causes desaturations.
The patient has since decreased his oxygen requirement to Venti amsk at 12 lpm with O2 sats rangin 89 to 97%.
The patient is currently being treated with Linezolid for a planned 21 day course for MRSA as well as Ceftazidime, again for a planned 21 day course for Pseudomonas.
Amikacin was added for syndergy and to avoid resistance with a planned 14 day course (ending dates specified on discharge meds).
The patient will continue to require ongoing Chest PT and physical therapy as well.
COPD: Has h/o COPD on montelukast, spiriva, advair, flovent, prednisone 10mg at home with PFT's showing FEV of 1.2 L (42% predicted), FEV1/FVC ratio of 42 (59% predicted), 6 L TLC, and elevated Residual Volume (193% predicited).
He was given Advair, Monteleukast, Prednisone 60 mg DAily tapered down to 30 mg Daily as well as Atrovent nebulizers.
The patient was maintained on Clonopin with hold parameters with Ativan rescues as needed.
Treated with MSSR 45 mg [**Hospital1 **] and IV morphine for breakthrough pain.
A KUB showed a non-obstructive bowel gas patterns and the patient's ostomy continues to drain well.
Treating pain as above with MS SR 45 [**Hospital1 **] with rescue doses.
Steroid Induced Hyperglycemia: Treated with 70/30 insulin [**Hospital1 **] at AM dose of 40 and PM dose of 22. .
He is s/p colectomy for Ulcerative colitis.
Ulcerative colitis: S/P colectomy and ileostomy.
Not on any medications for UC.
Communication: wife [**Name (NI) **] (h) [**Telephone/Fax (1) 56560**] (c) [**Telephone/Fax (1) 56561**], daughter [**Name (NI) **] [**Name (NI) 56562**] ([**Telephone/Fax (1) 56563**]  Medications on Admission: Montelukast 10 mg PO DAILY Tiotropium Bromide 18 mcg DAILY Flovent 110 2 puffs [**Hospital1 **] Prednisone 10mg daily mucinex 600mg tid Multivitamin PO DAILY Fluticasone-Salmeterol 250-50 mcg [**Hospital1 **] Benzonatate 100 mg PO TID Senna 8.6 mg PO BID PRN Docusate Sodium 100 mg PO BID PRN Nexium 40 mg twice a day.
Morphine 30 mg Tablet Sustained Release PO Q12H morphine 15mg IR PO q8hr PRN Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID   Discharge Medications: 1.
Hexavitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Nystatin 100,000 unit/mL Suspension Sig: 100,000 MLs PO QID (4 times a day).
Codeine-Guaifenesin 10-100 mg/5 mL Syrup Sig: 5-10 MLs PO Q6H (every 6 hours) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Lorazepam 0.5 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed for anxiety.
Acetylcysteine 20 % (200 mg/mL) Solution Sig: One (1) ML Miscell.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Heparin (Porcine) 5,000 unit/mL Solution Sig: 5000 (5000) units Injection TID (3 times a day): Continue until patient is regularly ambulatory, than may D/C.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Ipratropium Bromide 0.02 % Solution Sig: One (1) inhalation Inhalation Q4H (every 4 hours) as needed.
Clonazepam 0.25 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO three times a day: Hold for RR < 16.
Guaifenesin 600 mg Tablet Sustained Release Sig: Two (2) Tablet Sustained Release PO BID (2 times a day).
Morphine 15 mg Tablet Sustained Release Sig: Three (3) Tablet Sustained Release PO Q12H (every 12 hours).
Linezolid 600 mg/300 mL Parenteral Solution Sig: Six Hundred (600) mg Intravenous  Q12H (every 12 hours) for 5 days: First dose: [**2181-9-10**] Continue for total of 21 day course Last dose: [**2181-9-30**].
Ceftazidime-Dextrose (Iso-osm) 2 g/50 mL Piggyback Sig: Two (2) grams Intravenous  Q8H (every 8 hours) for 7 days: First dose: [**2181-9-12**] Continue for total of 21 day course Last dose: [**2181-10-2**].
Amikacin 250 mg/mL Solution Sig: One (1) gram Injection Q24H (every 24 hours) for 3 days: First dose: [**2181-9-15**] Continue for total 14 day course last dose: [**2181-9-28**].
Morphine 2 mg/mL Syringe Sig: Two (2) mg Injection Q4H (every 4 hours) as needed for breakthrough pain.
Prednisone 10 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily): Continue for 1 week.
Insulin NPH-Regular Human Rec 100 unit/mL (70-30) Suspension Sig: see instructions units Subcutaneous once a day: Please provide 40 units qam 22 units qhs.
Insulin Lispro (Human) 100 unit/mL Solution Sig: One (1) unit Subcutaneous four times a day: Please provide Humalog sliding scale with meals and at bedtime per provided sliding scale in addition to standing Insulin 70/30 .
Secondary: History of Non small cell Lung Ca s/p pneumonectomy Ulcerative Colitis Anemia   Discharge Condition: Fair.
Please take all medications as prescribed .
